期刊文献+

大剂量静脉注射胺碘酮治疗急性心肌梗死并顽固性室性心动过速15例临床护理 被引量:2

下载PDF
导出
摘要 对15例急性心肌梗死(AMI)并顽固性室性心动过速(VT)患者在复发时应用利多卡因和(或)电复律无效的情况下大剂量静脉用胺碘酮,首荆35mg/kg,继以0.5~1.5mg/min泵入维持,若控制不满意,可每隔30min再追加75~150mg负荷量,共2次,终止后逐渐减少静脉维持量到停用。观察室性心律失常得到控制的临床疗效、心电改变和副作用。结果7例在2h内、10例在24h内、12例在72h内室性心律失常得到有效控制,2例在减量或停用后复发,经追加胺碘酮用量后控制发作,2例死亡。静脉用量2h内380~520(462±65)mg,24h内用量1010—2150(1416±276)mg,静脉维持2~8(4.43±1.50)d。2例出现窦性心动过缓,其中1例心率〈50次/min,经减量后恢复正常。认为大剂量静脉注射胺碘酮治疗AMI并顽固性室性VT安全有效.副作用小。
作者 熊方华
机构地区 东海县人民医院
出处 《齐鲁护理杂志》 2009年第12期64-65,共2页 Journal of Qilu Nursing
  • 相关文献

参考文献3

二级参考文献14

  • 1袁贤奇,宋有城,朱俊,杨艳敏,郝云霞.心肌梗死后致命性心律失常的抢救治疗[J].临床急诊杂志,2000,1(3):103-104. 被引量:9
  • 2[1]Cleland JG,Clark A.Has the survival of the heart failure population changed?Lessons from trials.Am J Cardiol,1999,83:112-119.
  • 3[2]Matsumori A,Onok,Nishio R,et al.Amiodarone inhibits production of tumor necrosis factor-α by human mononuclear cells: a possible mechanism for its effect in heart failure.Circulation,1997,96(5):1 386-1 389.
  • 4[3]Amiodarone Trials Meta-Analysis Investigators.Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure:meta-analysis of individual data from 6 500 patients in randomised trials.Lancet,1997,350:1 417-1 424.
  • 5Antman EM, Anbe DT, Armstrong PW,et al.ACC/AHA guidlines for the management of patients with ST-elevation myocardial infarction-executive summary[J]. Circulation,2004,110:588
  • 6Hammill SC.Cardiac arrhythmias[J].JACC,2004,44(suppl 2):16A
  • 7Goldschlager N, Epstein AE, Naccarelli G, et al. Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology[J]. Arch Intern Med,2000,160:1 741
  • 8The American Heart Association in Collaboration with the International Liais on Committee on Resuscitation. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Part 6: Advance cardiovascular life support. Section 5: Phamacology I: Agents for Arrhythmias[J]. Circulation, 2000, 102(Suppl 8): I 112
  • 9Fuster V, Rydén LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation[J]. Eur Heart J,2001,22:1 852
  • 10Khan IA.Pharmacological cardioversion of recent onset atrial fibrillation[J]. Eur Heart J ,2004,25:1 274

共引文献400

同被引文献5

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部